Diversified Trust Co Has $904,000 Holdings in Neogen Co. (NASDAQ:NEOG)

Diversified Trust Co increased its position in shares of Neogen Co. (NASDAQ:NEOG) by 7.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 74,446 shares of the company’s stock after purchasing an additional 4,961 shares during the quarter. Diversified Trust Co’s holdings in Neogen were worth $904,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Franklin Resources Inc. raised its holdings in Neogen by 33.9% in the 3rd quarter. Franklin Resources Inc. now owns 923,918 shares of the company’s stock valued at $15,531,000 after buying an additional 233,796 shares during the last quarter. Neo Ivy Capital Management acquired a new stake in shares of Neogen during the 3rd quarter worth approximately $66,000. Geode Capital Management LLC grew its position in shares of Neogen by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 5,148,388 shares of the company’s stock worth $86,559,000 after buying an additional 20,387 shares during the period. Barclays PLC grew its position in shares of Neogen by 129.8% during the 3rd quarter. Barclays PLC now owns 366,753 shares of the company’s stock worth $6,165,000 after buying an additional 207,160 shares during the period. Finally, State Street Corp lifted its holdings in shares of Neogen by 3.1% in the 3rd quarter. State Street Corp now owns 7,932,192 shares of the company’s stock worth $133,340,000 after purchasing an additional 236,762 shares in the last quarter. Institutional investors own 96.73% of the company’s stock.

Wall Street Analyst Weigh In

NEOG has been the topic of a number of recent research reports. StockNews.com upgraded Neogen to a “sell” rating in a report on Monday, September 30th. Guggenheim initiated coverage on Neogen in a research note on Thursday, December 19th. They set a “buy” rating and a $15.00 target price on the stock.

Neogen Stock Performance

NASDAQ:NEOG opened at $13.07 on Friday. The business has a 50 day moving average of $13.54 and a 200 day moving average of $15.11. The company has a market capitalization of $2.83 billion, a price-to-earnings ratio of -118.82 and a beta of 1.23. Neogen Co. has a 1-year low of $11.46 and a 1-year high of $18.75. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.41 and a quick ratio of 2.79.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Thursday, October 10th. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.10 by ($0.03). Neogen had a negative net margin of 2.58% and a positive return on equity of 2.80%. The company had revenue of $217.00 million during the quarter, compared to the consensus estimate of $215.05 million. During the same quarter in the previous year, the firm posted $0.11 EPS. The business’s revenue for the quarter was down 5.2% compared to the same quarter last year. On average, sell-side analysts predict that Neogen Co. will post 0.5 earnings per share for the current fiscal year.

Neogen Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.